140 related articles for article (PubMed ID: 35759854)
1. Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score).
Puhr HC; Puhr R; Kuchling DA; Jahic L; Takats J; Reiter TJ; Paireder M; Jomrich G; Schoppmann SF; Berghoff AS; Preusser M; Ilhan-Mutlu A
ESMO Open; 2022 Aug; 7(4):100519. PubMed ID: 35759854
[TBL] [Abstract][Full Text] [Related]
2. Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome.
Puhr HC; Pablik E; Berghoff AS; Jomrich G; Schoppmann SF; Preusser M; Ilhan-Mutlu A
ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32188713
[TBL] [Abstract][Full Text] [Related]
3. Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study.
Du R; Ming J; Geng J; Zhu X; Zhang Y; Li S; Liu Z; Wang H; Wang Z; Tang L; Zhang X; Wu A; Bu Z; Yan Y; Li Z; Li Y; Li Z; Wang W
Radiat Oncol; 2022 Mar; 17(1):45. PubMed ID: 35241109
[TBL] [Abstract][Full Text] [Related]
4. Association of systemic inflammation and body mass index with survival in patients with resectable gastric or gastroesophageal junction adenocarcinomas.
Gao X; Pan Y; Han W; Hu C; Wang C; Chen L; Guo Y; Shi Y; Pan Y; Xie H; Yao L; Yang J; Zheng J; Li X; Liu X; Hong L; Li J; Li M; Ji G; Li Z; Xia J; Zhao Q; Fan D; Wu K; Nie Y
Cancer Biol Med; 2021 Feb; 18(1):283-297. PubMed ID: 33628601
[TBL] [Abstract][Full Text] [Related]
5. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
[TBL] [Abstract][Full Text] [Related]
8. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
9. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
10. Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting.
Nakayama I; Takahari D; Wakatsuki T; Osumi H; Chin K; Ogura M; Sato T; Suzuki T; Kamiimabeppu D; Ooki A; Suenaga M; Shinozaki E; Yamaguchi K
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32273288
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
12. Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma.
Kim S; Paget-Bailly S; Messager M; Nguyen T; Mathieu P; Lamfichekh N; Fein F; Fratté S; Cléau D; Lakkis Z; Jary M; Sakek N; Jacquin M; Foubert A; Bonnetain F; Mariette C; Fiteni F; Borg C
Eur J Surg Oncol; 2017 Jan; 43(1):218-225. PubMed ID: 27425578
[TBL] [Abstract][Full Text] [Related]
13. Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
Abraham M; Kordatou Z; Barriuso J; Lamarca A; Weaver JMJ; Cipriano C; Papaxoinis G; Backen A; Mansoor W
PLoS One; 2019; 14(11):e0224540. PubMed ID: 31774822
[TBL] [Abstract][Full Text] [Related]
14. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
Haj Mohammad N; Bernards N; van Putten M; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
Eur J Cancer; 2017 Jun; 78():28-36. PubMed ID: 28412586
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.
Vošmik M; Laco J; Sirák I; Dvořák J; Lochman P; Hodek M; Malá P; Rejchrt S; Repák R; Leško M; Ferko A; Ryška A; Melichar B; Petera J
Pathol Oncol Res; 2018 Apr; 24(2):373-383. PubMed ID: 28550507
[TBL] [Abstract][Full Text] [Related]
16. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.
Jomrich G; Paireder M; Kristo I; Baierl A; Ilhan-Mutlu A; Preusser M; Asari R; Schoppmann SF
Ann Surg; 2021 Mar; 273(3):532-541. PubMed ID: 31425286
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
18. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
Kulig P; Sierzega M; Pach R; Kolodziejczyk P; Kulig J;
Eur J Surg Oncol; 2016 Aug; 42(8):1215-21. PubMed ID: 27241921
[TBL] [Abstract][Full Text] [Related]
19. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors for survival in patients with resectable advanced gastric adenocarcinoma].
Medrano-Guzmán R; Valencia-Mercado D; Luna-Castillo M; García-Ríos LE; González-Rodríguez D
Cir Cir; 2016; 84(6):469-476. PubMed ID: 27039288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
